Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland

Vaccine

Volumn 25, Issue 52, 2007, Pages 8718-8725

  Mohler Kuo, Meichun ^a   Steffen, Robert ^b   Bopp, Matthias ^a   Jacobs, R Jake ^c   Mutsch, Margot ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Capitol Outcomes Research Inc   (United States)

Author keywords

Hepatitis A; Population survey; Risk factors; Vaccination

Indexed keywords

ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDEMIC DISEASE; EXPOSURE; FEMALE; HEALTH SURVEY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INFECTION RISK; LIFESPAN; MALE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; RISK FACTOR; SWITZERLAND; TRAVEL; VACCINATION; VIRUS TRANSMISSION;

ADULT; AWARENESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS A; HEPATITIS A VIRUS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SWITZERLAND; TRAVEL;

EID: 36749059122     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.033     Document Type: Article

References (29)

1. Jacobson K.H., and Koopman J.S. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 132 (2004) 1005-1022
2. Swiss Federal Office of Public Health (BAG). Laboratory and physician reports of acute hepatitis A infections, 1988-2003. http://www.bag.admin.ch/infreporting/gs03/hepatitis%20a.pdf; 2006 [accessed August 8, 2006, in German].
3. Mutsch M., Masserey Spicher V., Gut C., and Steffen R. Hepatitis A infections in travellers, 1988-2004. Clin Infect Dis 42 (2006) 490-497
4. Van der Eerden L.J., Bosman A., and Van Duynhoven Y.T. Surveillance of hepatitis A in the Netherlands 1993-2002. Ned Tijdschr Geneeskd 148 (2004) 1390-1394
5. Cotter S.M., Sansom S., Long T., Koch E., Kellerman S., Smith F., et al. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis 187 (2003) 1235-1240
6. Gisler S., Steffen R., and Mutsch M. Knowledge, attitudes, and practices among travellers to tropical and subtropical countries. Praxis 94 (2005) 967-974
7. Lopalco P.L., Salleras L., Barbuti S., Germinario C., Bruquera M., Buti M., et al. Hepatitis A and B in children and adolescents-what can we learn from Puglia (Italy) and Catalonia (Spain)?. Vaccine 19 (2000) 470-474
8. Wasley A., Samandari T., and Bell B.P. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 294 (2005) 194-201
9. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., and Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 294 (2005) 194-201
10. Centers for Disease Control and Prevention (CDC). Prevention of hepatitis A through active or passive immunization: recommendation of the Advisory Committee on Immunization Practices. MMWR 55 RR-7 (2006) 1-23
11. Centers for Disease Control and Prevention (CDC). Prevention of hepatitis A through active or passive immunization: recommendation of the Advisory Committee on Immunization Practices. MMWR 48 RR-12 (1999) 1-37
12. Swiss Federal Office of Public Health. Recommendation for the prevention of hepatitis A in Switzerland. Supplementum IX. http://www.bag.admin.ch/themen/medizin/00682/00684/01076/index.html?lang =de; 2007 [accessed March 12, 2007].
13. World Health Organization (WHO). International travel and health. http://www.who.int/ith; 2005 [accessed November 30, 2005].
14. StataCorp. Stata statistical software: release 7.0 (2001), Stata Corporation, College Station, TX
15. Swiss Federal Statistical Office. Annual statistics of the Swiss population (ESPOP) 2004. http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.Document. 81018.pdf#search=%22ESPOP%202005%22; 2005 [accessed June 20, 2006].
16. Jacobs R.J., Meyerhoff A.S., and Zink T. Hepatitis A immunization strategies: universal versus targeted approaches. Clin Pediatr (Phila) 44 (2005) 705-708
17. World Health Organization (WHO). Hepatitis A. http://www.who.int/csr/disease/hepatitis/en/HepatitisA_whocdscsredc2000_ 7.pdf; 2006 [accessed November 7, 2006].
18. De Serres G., Duval B., Shadmani R., Boulianne N., Pohani G., Naus M., et al. Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med 9 (2002) 10-16
19. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28 (2006) 112-125
20. Fitzsimons D., Grancois G., Alpers K., Radun D., Hallauer J., Jilg W., et al. Prevention of viral hepatitis in the Nordic countries and Germany. Scand J Infect Dis 37 (2005) 549-560
21. Morris-Cunnington M.C., Edmunds W.J., Miller E., and Brown D.W.G. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 159 (2004) 786-794
22. Mossong J., Putz L., Patiny S., and Schneider F. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect 134 (2006) 808-813
23. Swiss Federal Statistical Office. Statistical yearbook of Switzerland 2006 (2006), Neue Zürcher Zeitung, Zurich
24. Nainan O.V., Armstrong G.L., Han X.H., Williams I., Nell B.P., and Margolis H.S. Hepatitis A molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J Infect Dis 191 (2005) 957-963
25. Lundberg O., and Manderbacka K. Assessing reliability of a measure of self-rated health. Scand J Soc Med 24 (1996) 218-224
26. Zobel F., Thomas R., Arnaud S., de Preux E., Ramstein T., Spencer B., et al. Global evaluation of the Confederation's measures to reduce drug-related problems (ProMeDro): fourth synthesis report 1999-2002 (2003), Institut universitaire de médecine sociale et préventive, Lausanne
27. Narring F., Tschumper A., Inderwildi Bonivento L., et al. Gesundheit und Lebensstil 16- bis 20- Jähriger in der Schweiz (2002). SMASH 2002: Swiss multicenter adolescent survey on health 2002 (2004), IUMSP, Lausanne
28. Van Damme P., Banatvala J., Fay O., Iwarson S., McMahon B., Van Herck K., et al. Hepatitis A booster vaccination: is there a need?. Lancet 362 (2003) 1065-1071
29. Bauch C.T., Srinivasa Rao A.S.R., Pham B.Z., Krahn M., Gilca V., Duval B., et al. A dynamic model for assessing universal Hepatitis A vaccination in Canada. Vaccine 25 (2007) 1719-1726